13. The Role of Altered Energetics of Neurotransmitter Systems in Psychiatric Disease

  1. Robert G. Shulman2 and
  2. Douglas L. Rothman3
  1. Graeme F. Mason

Published Online: 18 AUG 2005

DOI: 10.1002/0470020520.ch13

Brain Energetics and Neuronal Activity: Applications to fMRI and Medicine

Brain Energetics and Neuronal Activity: Applications to fMRI and Medicine

How to Cite

Mason, G. F. (2004) The Role of Altered Energetics of Neurotransmitter Systems in Psychiatric Disease, in Brain Energetics and Neuronal Activity: Applications to fMRI and Medicine (eds R. G. Shulman and D. L. Rothman), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470020520.ch13

Editor Information

  1. 2

    Yale University School of Medicine, MR Center, P.O. Box 208043, New Haven, CT 06520-8043, USA

  2. 3

    Department of Diagnostic Radiology, Yale University School of Medicine, MR Center, P.O. Box 208043, New Haven, CT 06520-8043, USA

Author Information

  1. Department of Psychiatry, Yale University School of Medicine, MR Center, P.O. Box 208043, New Haven, CT 06520-8043, USA

Publication History

  1. Published Online: 18 AUG 2005
  2. Published Print: 29 MAR 2004

ISBN Information

Print ISBN: 9780470847206

Online ISBN: 9780470020524

SEARCH

Keywords:

  • glial–neuronal interactions;
  • neuropsychiatric disorders;
  • metabolic control analysis (MCA);
  • N-acetyl aspartate;
  • brain-derived neurotrophic factor (BDNF);
  • neurosteroids;
  • high-field magnets

Summary

This chapter contains sections titled:

  • Glial–Neuronal Interactions and Neuropsychiatric Disorders

  • 1H MRS and Glial–Neuronal Interactions

  • 13C MRS and Psychiatric Disorders

  • Future Directions

  • References